Correlation Engine 2.0
Clear Search sequence regions

  • baculovirus (3)
  • glycoprotein (1)
  • humans (1)
  • insect (2)
  • lyssavirus (1)
  • RVM (2)
  • vaccines (4)
  • virus- particles (1)
  • VLPs (6)
  • Sizes of these terms reflect their relevance to your search.

    Rabies is an ancient zoonotic disease that still causes the death of over 59,000 people worldwide each year. The rabies lyssavirus encodes five proteins, including the envelope glycoprotein and the matrix protein. RVGP is the only protein exposed on the surface of viral particle, and it can induce immune response with neutralizing antibody formation. RVM has the ability to assist with production process of virus-like particles. VLPs were produced in recombinant baculovirus system. In this work, two recombinant baculoviruses carrying the RVGP and RVM genes were constructed. From the infection and coinfection assays, we standardized the best multiplicity of infection and the best harvest time. Cell supernatants were collected, concentrated, and purified by sucrose gradient. Each step was used for protein detection through immunoassays. Sucrose gradient analysis enabled to verify the separation of VLPs from rBV. Through the negative contrast technique, we visualized structures resembling rabies VLPs produced in insect cells and rBV in the different fractions of the sucrose gradient. Using ELISA to measure total RVGP, the recovery efficiency of VLPs at each stage of the purification process was verified. Thus, these results encourage further studies to confirm whether rabies VLPs are a promising candidate for a veterinary rabies vaccine. © 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.


    Thaissa Consoni Bernardino, Renato Mancini Astray, Carlos Augusto Pereira, Vera Lucia Boldorini, Marta Maria Antoniazzi, Simone Gonçalves Silva Jared, Eutimio Gustavo Fernández Núñez, Soraia Attie Calil Jorge. Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach. Molecular biotechnology. 2021 Nov;63(11):1068-1080

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34228257

    View Full Text